Metabolic health company Berry Street has acquired the technology and intellectual property of MyScribe, an AI clinical assistant founded by Dr. Wasif Bokhari, who has joined Berry Street as Lead AI Engineer. The move brings MyScribe’s technology and its founder into Berry Street’s existing care platform, where AI tools support patients and clinicians alongside a network of more than 2,000 healthcare professionals. MyScribe’s standalone service is being wound down as Bokhari shifts his focus to developing AI across Berry Street’s patient and provider experiences.
Berry Street Acquires MyScribe to Expand AI Across Clinical Nutrition Care
The acquisition gives Berry Street both MyScribe’s underlying technology and the expertise of its founder, Dr. Wasif Bokhari, who has joined the company as Lead AI Engineer. Financial terms were not disclosed. MyScribe’s standalone service is being wound down, with its technology moving into Berry Street’s broader platform.
The deal highlights a growing strategy in healthcare technology: bringing specialized AI capabilities directly into care-delivery platforms rather than operating them as separate software products. For Berry Street, the focus is on embedding AI across two connected areas — the patient experience and the work clinicians perform to deliver care.
From a standalone clinical assistant to an integrated care platform
MyScribe was developed to make AI more useful for dietitians and other clinicians. Its founder says the original objective was to build technology that could support clinical professionals in their daily work. Berry Street now intends to apply that experience within a larger service that connects patients with clinicians and provides digital support between appointments.
Bokhari’s appointment is central to the transaction. At Berry Street, he will build AI across the patient and provider experience, as well as the models that support the company’s growth. His previous experience includes early AI engineering work at telehealth company Hims & Hers, serving as founding AI engineer at ShopMy, and working at Intel.
The acquisition is therefore more than a transfer of software assets. It brings a founder with experience building AI products into a company that already has a substantial clinical network and an established patient-facing platform.
The companies have not disclosed which specific MyScribe features or components will be incorporated first, whether existing MyScribe customers will be migrated, or how the acquired technology will be integrated into Berry Street’s systems.
AI and clinicians as a combined care model
Berry Street’s approach is built around combining digital tools with one-to-one clinical care. The company connects patients with a network of more than 2,000 clinicians and offers nutrition therapy for metabolic health and related needs. Patients work directly with a clinician and use the Berry Street app between visits for AI-powered guidance, meal tracking, and synchronization of health information from wearables and laboratory results.
The model places AI in a supporting role rather than positioning it as a replacement for professional care. Clinicians remain responsible for the one-to-one relationship, while software can help patients maintain engagement and give providers additional information between consultations.
This approach is particularly relevant to nutrition therapy, where progress often depends on patterns that develop over time. Food choices, activity, health measurements, and patient-reported information can all contribute to a broader picture of an individual’s needs. Digital tools may help organize those signals, but their usefulness depends on data quality, clinical context, and appropriate professional oversight.
Berry Street says its services are covered by insurance in most cases, allowing patients to pay little or nothing out of pocket. This insurance-based model is an important part of its strategy: the company is combining clinical access with technology rather than relying exclusively on direct-to-consumer subscriptions.
The wider shift toward AI-enabled healthcare operations
Healthcare organizations are exploring AI across patient communication, clinical documentation, administrative workflows, and personalized support. Specialized assistants can help professionals work with information more efficiently, while patient-facing tools can make digital services available outside scheduled appointments.
However, clinical AI presents different requirements from general-purpose productivity software. Systems used in healthcare need to protect sensitive information, maintain appropriate access controls, and make it possible for professionals to review relevant outputs. If AI-generated information influences clinical decisions, organizations also need processes for evaluating accuracy, identifying errors, and determining when human intervention is necessary.
The distinction between administrative assistance and clinical decision support is important. The announcement does not specify whether MyScribe’s acquired technology will be used for documentation, clinical recommendations, workflow automation, or other functions at Berry Street. The company has described a broad AI development role, but detailed product capabilities and deployment plans have not yet been announced.
Building on Berry Street’s existing AI strategy
The acquisition follows Berry Street’s August 2026 merger with Healthify, which brought together Berry Street’s U.S. clinician network and insurance-covered nutrition services with Healthify’s AI-powered nutrition and wellness technology. The combined organization reported a network of more than 2,000 clinicians and Healthify’s reach of more than 45 million users across over 20 cultures.
That merger established a broader technology and clinical foundation. The MyScribe acquisition adds another specialized AI capability, this time originating from a product built specifically for clinicians.
The strategic question is how Berry Street will combine these capabilities without creating fragmented tools for patients and providers. A unified platform could help connect patient engagement, nutrition tracking, clinician workflows, and health information. But integration will require consistent data management, reliable performance, privacy safeguards, and clear boundaries around AI-generated outputs.
For the wider healthtech market, the deal illustrates how healthcare platforms are using acquisitions and specialist engineering talent to deepen their AI capabilities. Rather than developing every component internally, companies can bring in existing technology and the teams or founders who understand how it was built.
Berry Street’s next test will be demonstrating how MyScribe’s technology improves its actual care workflows. The acquisition provides the company with additional AI assets and leadership, but the announcement does not yet quantify expected efficiency gains, patient outcomes, or clinical productivity improvements.
The direction is clear: Berry Street wants AI to become part of the infrastructure supporting both sides of the care relationship. Whether that approach delivers measurable value will depend on how effectively the company translates its technology into safer, more accessible, and more coordinated nutrition care.
Market Landscape
The Berry Street–MyScribe deal sits within three developments shaping AI in healthcare:
- Clinical workflow automation: Healthcare technology companies are building AI assistants to support clinicians with information management, documentation, and routine tasks. The commercial opportunity depends on whether these tools reduce administrative work without introducing additional review burdens.
- Personalized digital health: AI-powered applications can help organize patient-reported information, nutrition records, wearable data, and other health signals to support ongoing engagement between clinical appointments.
- Platform consolidation: Healthcare companies are acquiring specialized AI technology and talent to integrate capabilities into established patient-care platforms instead of relying solely on standalone products.
Competition is developing across several categories, including clinical AI assistants, electronic health record platforms, digital health applications, and AI-enabled care management. Companies such as Microsoft, Google, and Amazon are also expanding their healthcare technology capabilities.
Berry Street’s differentiation lies in combining AI with an existing clinician network and an insurance-oriented nutrition therapy model. Its opportunity is to make digital support more useful across the full care journey, rather than treating AI as a separate consumer application.
The main challenges remain data privacy, clinical accuracy, integration with care workflows, and evidence that AI tools improve patient or provider outcomes. In healthcare, adoption will depend on trust and measurable value as much as technological capability.
Top Insights
- Berry Street acquired MyScribe’s technology and intellectual property, bringing founder Dr. Wasif Bokhari into the company as Lead AI Engineer.
- MyScribe’s standalone service is being wound down as its technology moves into Berry Street’s broader healthcare platform.
- Bokhari will develop AI across patient and provider experiences, as well as models supporting Berry Street’s growth.
- Berry Street combines AI-powered patient tools with a network of more than 2,000 clinicians delivering personalized nutrition care.
- The acquisition follows Berry Street’s 2026 merger with Healthify, adding another specialized AI capability to its expanding platform.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
